To date, ependymoma has never been reported in patients that are hosting pathogenic variants of POLR2A, consequently, this report opens the way for further studies to explore the possibility of a differential, clinical and functional impact of the different classes of these variants and their possible contribution to the predisposition to ependymomas [78]. This evidence concerns the gene POLR2A and ependymoma.